Want to join the conversation?
$MYL said it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Azacitidine for Injection. This will treat five French-American-British (FAB) subtypes of myelodysplastic syndrome, a blood cell disorder that can occur as result of cancer treatments or can progress to leukemia.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?